A Double-Blind, Placebo-Controlled Phase 2a Proof-Of-Concept Study of the Phosphodiesterase Type 4 Inhibitor, Apremilast, for the Treatment of Alcohol Use DisorderBarbara MasonNEUROPSYCHOPHARMACOLOGY（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
